3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
2
Plasma cell
2
Other hematologic neoplasm
2
Lymphoid
2
Head & Neck
2
Gynecologic
2
Gastrointestinal
2
CNS
2
Myeloid
1
Genitourinary
1
Endocrine
1
Dermatologic
1
Breast
1
Conditions
Histiocytosis, Langerhans-Cell
3
Neurofibroma, Plexiform
2
Neuroblastoma
2
Neoplasms
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Acute
2
Hematologic Neoplasms
2
Glioma
2
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Thrombocytosis
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Oligodendroglioma
1
Neurofibromatosis 1
1
Neurocytoma
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Lymphoproliferative Disorders
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Interventions
Flow Cytometry
3
Psychiatric Rehabilitation
2
Methylprednisolone
2
Immunologic Techniques
2
Azacitidine
2
Alemtuzumab
2
trametinib
1
sargramostim
1
ruxolitinib
1
rucaparib
1
ixabepilone
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
dabrafenib
1
cobimetinib
1
cc-486
1
aldesleukin
1
abiraterone
1
Zoledronic Acid
1
Vemurafenib
1
Tacrolimus
1
Standard of Care
1
Quality of Life
1
Prednisone
1
Practice Guidelines as Topic
1
Patient Reported Outcome Measures
1
Palliative Care
1
Paclitaxel
1
Moxifloxacin
1
Molecular Diagnostic Techniques
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ovarian Neoplasms
×
trametinib
×
Myeloid
×
Clear all
NCT07440290
2026-02-27
DETERMINE
Cancer Research UK
Phase 2/3
Not yet recruiting
30 enrolled